Assignee
ALLYSTA PHARMACEUTICALS INC
US·6 granted patents·5 pending applications·6 citations·filing 2016–2024
Top patents by PatentIndex Score
11 records- 0193US10537608B2Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·6 cites·16 claims
- 0280US2023074446A1Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0378US2022331393A1Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0477US11273197B2Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·0 cites·7 claims
- 0575US11464825B2Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2021·Granted Oct 11, 2022·0 cites·17 claims
- 0674US2025099533A1Adiponectin peptidomimetics formulationsALLYSTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0769US12201668B2Adiponectin peptidomimetics formulationsALLYSTA PHARMACEUTICALS INC·Filed 2019·Granted Jan 21, 2025·0 cites·9 claims
- 0865US10987401B2Adiponectin peptidomimetics for treating ocular disordersALLYSTA PHARMACEUTICALS INC·Filed 2016·Granted Apr 27, 2021·0 cites·18 claims
- 0964US2024382564A1Methods and Compositions for Treating Muscular Dystrophy and Memory ImpairmentALLYSTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1060US2023021946A1Monomeric fusion peptides and method of use thereofALLYSTA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1147US11524045B2Peptides for dry eye diseaseALLYSTA PHARMACEUTICALS INC·Filed 2018·Granted Dec 13, 2022·0 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →